• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化因子分子异质性的种属特异性差异。

Species-specific variations in the molecular heterogeneity of the platelet-activating factor.

作者信息

Ramesha C S, Pickett W C

出版信息

J Immunol. 1987 Mar 1;138(5):1559-63.

PMID:3100641
Abstract

The molecular heterogeneity of platelet-activating factor (PAF) synthesized by unstimulated and Ca2+ ionophore (A23187)-stimulated PMN from rat, mouse, and guinea pig and by rat basophilic leukemia (RBL) cells was investigated by gas chromatography-negative ion chemical ionization mass spectrometry. Several molecular species of PAF ranging from C14:0 to C19:0 were detected in all of the cells studied. PAF produced by each cell type exhibited a unique pattern of molecular species distribution. Although C16:0 was the major PAF molecular species of rat PMN and RBL cells representing 96% and 85% of the total PAF, respectively, PAF from mice PMN contained 81% of C16:0, 10% of C18:1, and 6% of C18:0. Alternatively, A23187-stimulated guinea pig PMN yielded PAF molecular species 35% in C16:0, 35% in C17:0, 8% in C18:1, and 3% in C18:0. Small but significant differences in the PAF molecular species distribution of resting and ionophore stimulated cells were also observed. In contrast to the PAF molecular species composition, the precursor 1-O-alkyl-2-acyl-glycero-3-phosphocholine of all the cell types was predominantly hexadecyl (C16:0) alkyl chain in the sn-1 position, representing 60 to 80% of the total 1-O-alkyl-2-acyl-glycero-3-phosphocholine. Thus, these results not only indicate a high degree of selectivity for utilization of precursor substrates for PAF biosynthesis, but also demonstrate that the selectivity is species specific.

摘要

通过气相色谱-负离子化学电离质谱法,研究了未刺激的以及经钙离子载体(A23187)刺激的大鼠、小鼠和豚鼠中性粒细胞(PMN)以及大鼠嗜碱性白血病(RBL)细胞合成的血小板活化因子(PAF)的分子异质性。在所有研究的细胞中均检测到了几种碳链长度从C14:0到C19:0的PAF分子种类。每种细胞类型产生的PAF呈现出独特的分子种类分布模式。虽然C16:0是大鼠PMN和RBL细胞中主要的PAF分子种类,分别占总PAF的96%和85%,但小鼠PMN产生的PAF中C16:0占81%,C18:1占10%,C18:0占6%。另外,经A23187刺激的豚鼠PMN产生的PAF分子种类中,C16:0占35%,C17:0占35%,C18:1占8%,C18:0占3%。还观察到静息细胞和经离子载体刺激的细胞在PAF分子种类分布上存在微小但显著的差异。与PAF分子种类组成不同,所有细胞类型的前体1-O-烷基-2-酰基甘油-3-磷酸胆碱在sn-1位主要是十六烷基(C16:0)烷基链,占总1-O-烷基-2-酰基甘油-3-磷酸胆碱的60%至80%。因此,这些结果不仅表明PAF生物合成中前体底物利用具有高度选择性,还证明这种选择性具有物种特异性。

相似文献

1
Species-specific variations in the molecular heterogeneity of the platelet-activating factor.血小板活化因子分子异质性的种属特异性差异。
J Immunol. 1987 Mar 1;138(5):1559-63.
2
Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.
J Immunol. 1985 Feb;134(2):1090-3.
3
Human neutrophil platelet-activating factor: molecular heterogeneity in unstimulated and ionophore-stimulated cells.
Biochim Biophys Acta. 1987 Sep 4;921(1):60-6. doi: 10.1016/0005-2760(87)90170-6.
4
Analysis of effector cell-derived lyso platelet activating factor by electron capture negative ion mass spectrometry.
Biol Mass Spectrom. 1991 Sep;20(9):545-52. doi: 10.1002/bms.1200200907.
5
Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18).免疫激活和细胞脂肪酸水平对小鼠肥大细胞(PT-18)内血小板活化因子分解代谢的影响。
Biochim Biophys Acta. 1989 Nov 6;1006(1):41-51. doi: 10.1016/0005-2760(89)90321-4.
6
Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
Drugs Exp Clin Res. 1991;17(7):343-9.
7
Identification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometry.通过高效液相色谱-电喷雾电离串联质谱法鉴定和定量甘油磷脂血小板活化因子家族在神经元分化过程中的变化。
Anal Chem. 2007 Nov 15;79(22):8539-48. doi: 10.1021/ac0712291. Epub 2007 Oct 20.
8
Release of newly synthesized platelet-activating factor (PAF) from human polymorphonuclear leukocytes under in vivo conditions. Contribution of PAF-releasing factor in serum.
J Immunol. 1992 Feb 1;148(3):872-80.
9
Dietary salt, blood pressure and circulating levels of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in patients with essential hypertension.
J Lipid Mediat. 1989 Nov-Dec;1(6):341-8.
10
Renal allograft platelet activating factor synthesis during acute cellular rejection.急性细胞性排斥反应期间同种异体肾移植血小板活化因子的合成
J Lipid Mediat. 1991 Jul-Aug;4(1):69-81.

引用本文的文献

1
Eosinophil migration in response to three molecular species of platelet activating factor.
Inflamm Res. 1996 Jun;45(6):265-7. doi: 10.1007/BF02280988.
2
Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation.丁酸盐诱导分化后EoL-1细胞中人血小板活化因子受体基因的表达
Biochem J. 1995 Feb 1;305 ( Pt 3)(Pt 3):829-35. doi: 10.1042/bj3050829.
3
Structural and (patho)physiological diversity of PAF.血小板活化因子的结构与(病理)生理多样性。
Clin Rev Allergy. 1994 Winter;12(4):329-59. doi: 10.1007/BF02802299.
4
Effect of platelet activating factor (PAF) on the migration of human lymphocytes.血小板活化因子(PAF)对人淋巴细胞迁移的影响。
Thorax. 1995 Mar;50(3):265-9. doi: 10.1136/thx.50.3.265.
5
Molecular heterogeneity of platelet-activating factor (PAF) in rat glandular stomach determined by gas chromatography/mass spectrometry. PAF molecular species changes upon water-immersion stress.
Lipids. 1991 Dec;26(12):1347-53. doi: 10.1007/BF02536564.
6
Determination of platelet-activating factor by a chemiluminescence method and its application to stimulated guinea pig neutrophils.
Lipids. 1991 Dec;26(12):1117-21. doi: 10.1007/BF02536513.
7
Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils.正常及粒细胞-巨噬细胞集落刺激因子预刺激的人嗜酸性粒细胞合成的血小板活化因子的特性分析
Immunology. 1992 Dec;77(4):500-4.